PBK/TOPK expression was also significantly correlated with mutations of MMR genes (MSH2, MSH3, MSH4, MSH6 and PMS2), supporting the association between PBK/TOPK and MSI colon cancer. This evidence concerns the gene MSH4 and malignant colon neoplasm.